tert-Butyl acrylate → HCID 59456972, 화합물

HRID 1711849노트

반응식

HRID 1711849 반응식
Br[C:2]1[CH:13]=[N:12][C:5]2[NH:6][C:7](=[O:11])[NH:8][C:9](=[O:10])[C:4]=2[CH:3]=1.[C:14]([O:18]C(C)(C)C)(=[O:17])[CH:15]=[CH2:16].C(N(C(C)C)C(C)C)C.CC1C=CC=CC=1P(C1C=CC=CC=1C)C1C=CC=CC=1C>C(#N)CC.CN(C=O)C.CC([O-])=O.CC([O-])=O.[Pd+2]>[O:11]=[C:7]1[NH:6][C:5]2[N:12]=[CH:13][C:2](/[CH:16]=[CH:15]/[C:14]([OH:18])=[O:17])=[CH:3][C:4]=2[C:9](=[O:10])[NH:8]1

참가 물질

8

반응물 4

HCID 15458tert-Butyl acrylateHCID 80271Tri-o-tolylphosphineHCID 81531DiisopropylethylamineHCID 235841046-Bromopyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione

생성물 1

HCID 59456972HCID 59456972, 화합물수율 103.6%

시약·촉매·용매 3

HCID 167845palladium(II) acetate촉매HCID 6228Dimethylformamide용매HCID 7854Propionitrile용매

실험 절차

A suspension of 6-bromo-1H-pyrido[2,3-d]pyrimidine-2,4-dione (430 mg, 1.59 mmol) in propionitrile (8 mL) and DMF (2 mL) was treated with tert-butyl acrylate (0.93 mL, 6.4 mmol), (i-Pr)2EtN (0.6 mL, 3.3 mmol) and P(o-tol)3 (100 mg, 0.32 mmol). The solution was deoxygenated with Ar for 20 min. Pd(OAc)2 (36 mg, 0.16 mmol) was added and the mixture was deoxygenated with a stream of Ar for 10 min. The mixture was heated to reflux for 17 h, then allowed to cool. The resulting precipitate was isolated by filtration to give the title compound (384 mg, 83%) as a gray solid: 1H NMR (300 MHz, DMSO-d6) δ 11.88 (s, 1H), 11.54 (s, 1H), 8.96 (d, J=2.2 Hz, 1H), 8.53 (d, J=2.2 Hz, 1H), 7.65 (d, J=16.1 Hz, 1H), 6.72 (d, J=16.1 Hz, 1H), 1.49 (s, 9H); ESI MS m/e 290 (M+H)+.

후처리

  1. customThe solution was deoxygenated with Ar for 20 min
  2. customthe mixture was deoxygenated with a stream of Ar for 10 min
  3. temperatureThe mixture was heated
  4. temperatureto reflux for 17 h
  5. temperatureto cool
  6. customThe resulting precipitate was isolated by filtration

출처 및 근거

ORD 기록
ord-ed9e2f64966941678584a4e3cb246b14
출처 데이터셋
uspto-grants-2010_09
특허 번호
US07790709B2

반응 노트

불러오는 중…